DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $106,986,923 | +0.3% | 431,225 | -3.0% | 0.42% | +5.8% |
| Q2 2023 | $106,704,480 | -5.9% | 444,602 | -1.2% | 0.40% | -10.9% |
| Q1 2023 | $113,449,505 | -8.3% | 450,125 | -3.5% | 0.45% | -14.6% |
| Q4 2022 | $123,769,858 | -2.3% | 466,317 | -4.9% | 0.53% | -2.8% |
| Q3 2022 | $126,704,000 | +3.2% | 490,544 | +1.3% | 0.54% | +6.5% |
| Q2 2022 | $122,796,000 | -12.8% | 484,366 | +0.9% | 0.51% | +4.7% |
| Q1 2022 | $140,842,000 | -12.4% | 480,152 | -1.8% | 0.48% | -6.4% |
| Q4 2021 | $160,816,000 | +5.8% | 488,787 | -2.1% | 0.52% | -2.3% |
| Q3 2021 | $151,997,000 | +9.5% | 499,262 | -3.4% | 0.53% | +12.3% |
| Q2 2021 | $138,747,000 | +13.1% | 517,021 | -5.1% | 0.47% | +8.0% |
| Q1 2021 | $122,633,000 | -4.6% | 544,842 | -5.9% | 0.44% | -4.6% |
| Q4 2020 | $128,595,000 | -0.3% | 578,892 | -3.3% | 0.46% | -10.0% |
| Q3 2020 | $128,919,000 | +12.5% | 598,761 | -7.6% | 0.51% | +9.5% |
| Q2 2020 | $114,589,000 | +18.3% | 648,019 | -7.4% | 0.46% | +3.1% |
| Q1 2020 | $96,839,000 | -11.5% | 699,646 | -1.8% | 0.45% | +8.9% |
| Q4 2019 | $109,378,000 | +6.0% | 712,655 | -0.2% | 0.41% | -2.1% |
| Q3 2019 | $103,140,000 | +1.9% | 714,117 | +0.8% | 0.42% | +1.0% |
| Q2 2019 | $101,207,000 | +8.0% | 708,139 | +0.1% | 0.42% | +8.3% |
| Q1 2019 | $93,670,000 | +30.7% | 707,311 | +1.8% | 0.39% | +10.6% |
| Q4 2018 | $71,666,000 | -4.5% | 694,994 | +0.7% | 0.35% | +12.5% |
| Q3 2018 | $75,027,000 | +8.1% | 690,486 | -1.8% | 0.31% | +3.3% |
| Q2 2018 | $69,414,000 | -1.3% | 703,428 | -2.1% | 0.30% | -3.8% |
| Q1 2018 | $70,344,000 | +2.2% | 718,457 | -3.1% | 0.31% | +5.7% |
| Q4 2017 | $68,812,000 | -16.5% | 741,375 | -22.9% | 0.30% | -20.6% |
| Q3 2017 | $82,441,000 | -0.0% | 961,066 | -1.7% | 0.37% | -5.6% |
| Q2 2017 | $82,481,000 | +0.1% | 977,381 | +1.4% | 0.40% | -2.5% |
| Q1 2017 | $82,422,000 | +10.3% | 963,692 | +0.4% | 0.40% | +2.3% |
| Q4 2016 | $74,711,000 | +24.2% | 959,804 | +25.0% | 0.40% | +20.4% |
| Q3 2016 | $60,170,000 | -31.5% | 767,557 | -11.8% | 0.33% | -32.9% |
| Q2 2016 | $87,892,000 | +6.7% | 870,220 | +0.2% | 0.49% | +4.0% |
| Q1 2016 | $82,353,000 | +1.3% | 868,162 | -0.8% | 0.47% | -1.3% |
| Q4 2015 | $81,300,000 | +11.8% | 875,335 | +2.6% | 0.48% | +5.1% |
| Q3 2015 | $72,710,000 | +2.6% | 853,301 | +3.1% | 0.45% | +7.1% |
| Q2 2015 | $70,859,000 | +2.5% | 827,888 | +1.7% | 0.42% | +1.7% |
| Q1 2015 | $69,112,000 | +9.7% | 814,041 | +10.7% | 0.42% | +5.8% |
| Q4 2014 | $63,004,000 | +20.5% | 735,091 | +6.8% | 0.39% | +16.6% |
| Q3 2014 | $52,285,000 | +8.5% | 688,138 | +12.4% | 0.34% | +0.9% |
| Q2 2014 | $48,183,000 | +11.6% | 611,990 | +6.3% | 0.34% | +8.4% |
| Q1 2014 | $43,162,000 | +1.0% | 575,489 | +4.0% | 0.31% | -1.0% |
| Q4 2013 | $42,724,000 | +23.1% | 553,416 | +10.5% | 0.31% | +10.2% |
| Q3 2013 | $34,713,000 | +2036.2% | 500,763 | +1850.8% | 0.28% | -19.4% |
| Q2 2013 | $1,625,000 | – | 25,670 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |